{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:54:05Z","timestamp":1788339245985,"version":"build-2803163510"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-025-08841-y","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T09:05:25Z","timestamp":1759136725000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Isoleucyl-tRNA synthetase depletion reveals vulnerabilities in Mycobacterium abscessus and Mycobacterium marinum"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7678-951X","authenticated-orcid":false,"given":"Dan","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weile","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5790-7071","authenticated-orcid":false,"given":"Yicheng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghui","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9898-9472","authenticated-orcid":false,"given":"Siguo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7235-3046","authenticated-orcid":false,"given":"Zhe","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"8841_CR1","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41579-020-0331-1","volume":"18","author":"MD Johansen","year":"2020","unstructured":"Johansen, M. D., Herrmann, J.-L. & Kremer, L. Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus. Nat. Rev. Microbiol. 18, 392\u2013407 (2020).","journal-title":"Nat. Rev. Microbiol."},{"key":"8841_CR2","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.cmi.2023.08.035","volume":"30","author":"C Cristancho-Rojas","year":"2024","unstructured":"Cristancho-Rojas, C. et al. Epidemiology of Mycobacterium abscessus. Clin. Microbiol. Infect. 30, 712\u2013717 (2024).","journal-title":"Clin. Microbiol. Infect."},{"key":"8841_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.micres.2016.11.007","volume":"195","author":"S Yan","year":"2017","unstructured":"Yan, S. et al. Overexpression of Rv2788 increases Mycobacterium stresses survival. Microbiol. Res. 195, 51\u201359 (2017).","journal-title":"Microbiol. Res."},{"key":"8841_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0378-1097(04)00017-5","volume":"232","author":"KM Ruley","year":"2004","unstructured":"Ruley, K. M. et al. Identification of Mycobacterium marinum virulence genes using signature-tagged mutagenesis and the goldfish model of mycobacterial pathogenesis. FEMS Microbiol. Lett. 232, 75\u201381 (2004).","journal-title":"FEMS Microbiol. Lett."},{"key":"8841_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0378-1097(03)00446-4","volume":"225","author":"MG Prouty","year":"2003","unstructured":"Prouty, M. G., Correa, N. E., Barker, L. P., Jagadeeswaran, P. & Klose, K. E. Zebrafish-Mycobacterium marinum model for mycobacterial pathogenesis. FEMS Microbiol. Lett. 225, 177\u2013182 (2003).","journal-title":"FEMS Microbiol. Lett."},{"key":"8841_CR6","doi-asserted-by":"publisher","first-page":"3920","DOI":"10.1073\/pnas.002024599","volume":"99","author":"K Chan","year":"2002","unstructured":"Chan, K. et al. Complex pattern of Mycobacterium marinum gene expression during long-term granulomatous infection. Proc. Natl. Acad. Sci. USA 99, 3920\u20133925 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"8841_CR7","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1128\/iai.62.8.3222-3229.1994","volume":"62","author":"L Ramakrishnan","year":"1994","unstructured":"Ramakrishnan, L. & Falkow, S. Mycobacterium marinum persists in cultured mammalian cells in a temperature-restricted fashion. Infect. Immun. 62, 3222\u20133229 (1994).","journal-title":"Infect. Immun."},{"key":"8841_CR8","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41573-019-0026-3","volume":"18","author":"NH Kwon","year":"2019","unstructured":"Kwon, N. H., Fox, P. L. & Kim, S. Aminoacyl-tRNA synthetases as therapeutic targets. Nat. Rev. Drug Discov. 18, 629\u2013650 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"8841_CR9","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202202024RR","volume":"37","author":"S Gupta","year":"2023","unstructured":"Gupta, S. et al. Aminoacyl-tRNA synthetase - a molecular multitasker. FASEB J. 37, e23219 (2023).","journal-title":"FASEB J."},{"key":"8841_CR10","doi-asserted-by":"publisher","first-page":"e00240","DOI":"10.1128\/AAC.00240-19","volume":"63","author":"D Tenero","year":"2019","unstructured":"Tenero, D. et al. First-time-in-human study and prediction of early bactericidal activity for GSK3036656, a potent leucyl-tRNA synthetase inhibitor for tuberculosis treatment. Antimicrob. Agents Chemother. 63, e00240\u201319 (2019).","journal-title":"Antimicrob. Agents Chemother."},{"key":"8841_CR11","doi-asserted-by":"publisher","first-page":"e01577","DOI":"10.1128\/AAC.01577-19","volume":"64","author":"W Dong","year":"2020","unstructured":"Dong, W. et al. In vitro susceptibility testing of GSK656 against Mycobacterium species. Antimicrob. Agents Chemother. 64, e01577\u201319 (2020).","journal-title":"Antimicrob. Agents Chemother."},{"key":"8841_CR12","doi-asserted-by":"publisher","first-page":"8011","DOI":"10.1021\/acs.jmedchem.7b00631","volume":"60","author":"X Li","year":"2017","unstructured":"Li, X. et al. Discovery of a potent and specific M. tuberculosis leucyl-tRNA synthetase inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol (GSK656). J. Med. Chem. 60, 8011\u20138026 (2017).","journal-title":"J. Med. Chem."},{"key":"8841_CR13","doi-asserted-by":"publisher","first-page":"9995","DOI":"10.1021\/bi9603027","volume":"35","author":"M Sassanfar","year":"1996","unstructured":"Sassanfar, M., Kranz, J. E., Gallant, P., Schimmel, P. & Shiba, K. A eubacterial Mycobacterium tuberculosis tRNA synthetase is eukaryote-like and resistant to a eubacterial-specific antisynthetase drug. Biochemistry 35, 9995\u201310003 (1996).","journal-title":"Biochemistry"},{"key":"8841_CR14","doi-asserted-by":"publisher","first-page":"4579","DOI":"10.1016\/j.cell.2021.06.033","volume":"184","author":"B Bosch","year":"2021","unstructured":"Bosch, B. et al. Genome-wide gene expression tuning reveals diverse vulnerabilities of M. tuberculosis. Cell 184, 4579\u20134592.e24 (2021).","journal-title":"Cell"},{"key":"8841_CR15","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1093\/nar\/gni023","volume":"33","author":"MCJ Blokpoel","year":"2005","unstructured":"Blokpoel, M. C. J. et al. Tetracycline-inducible gene regulation in mycobacteria. Nucleic Acids Res. 33, e22 (2005).","journal-title":"Nucleic Acids Res."},{"key":"8841_CR16","doi-asserted-by":"publisher","first-page":"102626","DOI":"10.1016\/j.tube.2025.102626","volume":"152","author":"W Xie","year":"2025","unstructured":"Xie, W., Luo, D., Wu, M., Sun, Y. & Wang, Z. The evaluation of Phenylalanine-tRNA ligase beta unit (PheT), as a potential target in Mycobacterium abscessus. Tuberculosis152, 102626 (2025).","journal-title":"Tuberculosis"},{"key":"8841_CR17","doi-asserted-by":"publisher","first-page":"e00093","DOI":"10.1128\/aac.00093-22","volume":"66","author":"N Kurepina","year":"2022","unstructured":"Kurepina, N. et al. CRISPR inhibition of essential peptidoglycan biosynthesis genes in Mycobacterium abscessus and its impact on \u03b2-lactam susceptibility. Antimicrob. Agents Chemother. 66, e00093\u201322 (2022).","journal-title":"Antimicrob. Agents Chemother."},{"key":"8841_CR18","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00631-23","volume":"11","author":"TQ Nguyen","year":"2023","unstructured":"Nguyen, T. Q. et al. CRISPR interference-based inhibition of MAB_0055c expression alters drug sensitivity in Mycobacterium abscessus. Microbiol. Spectr. 11, e0063123 (2023).","journal-title":"Microbiol. Spectr."},{"key":"8841_CR19","doi-asserted-by":"crossref","unstructured":"Baughn, A. D. & Rhee, K. Y. Metabolomics of central carbon metabolism in Mycobacterium tuberculosis. Microbiol. Spectr. 2, MGM2-0026-2013 (2014).","DOI":"10.1128\/microbiolspec.MGM2-0026-2013"},{"key":"8841_CR20","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nrmicro3349","volume":"12","author":"A Gouzy","year":"2014","unstructured":"Gouzy, A., Poquet, Y. & Neyrolles, O. Nitrogen metabolism in Mycobacterium tuberculosis physiology and virulence. Nat. Rev. Microbiol. 12, 729\u2013737 (2014).","journal-title":"Nat. Rev. Microbiol."},{"key":"8841_CR21","doi-asserted-by":"publisher","first-page":"4376","DOI":"10.1073\/pnas.0711159105","volume":"105","author":"AK Pandey","year":"2008","unstructured":"Pandey, A. K. & Sassetti, C. M. Mycobacterial persistence requires the utilization of host cholesterol. Proc. Natl. Acad. Sci. USA 105, 4376\u20134380 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"8841_CR22","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.41129","volume":"8","author":"A Agapova","year":"2019","unstructured":"Agapova, A. et al. Flexible nitrogen utilisation by the metabolic generalist pathogen Mycobacterium tuberculosis. Elife 8, e41129 (2019).","journal-title":"Elife"},{"key":"8841_CR23","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2207505119","volume":"119","author":"AM Crowe","year":"2022","unstructured":"Crowe, A. M. et al. The unusual convergence of steroid catabolic pathways in Mycobacterium abscessus. Proc. Natl. Acad. Sci. USA 119, e2207505119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"8841_CR24","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.3390\/ijms20051032","volume":"20","author":"R van Wyk","year":"2019","unstructured":"van Wyk, R., van Wyk, M., Mashele, S. S., Nelson, D. R. & Syed, K. Comprehensive comparative analysis of cholesterol catabolic genes\/proteins in mycobacterial species. Int J. Mol. Sci. 20, 1032 (2019).","journal-title":"Int J. Mol. Sci."},{"key":"8841_CR25","doi-asserted-by":"crossref","unstructured":"Sia, J. K. & Rengarajan, J. Immunology of Mycobacterium tuberculosis infections. Microbiol. Spectr. 7, GPP3-0022-2018 (2019).","DOI":"10.1128\/microbiolspec.GPP3-0022-2018"},{"key":"8841_CR26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2024571118","volume":"118","author":"A Gouzy","year":"2021","unstructured":"Gouzy, A., Healy, C., Black, K. A., Rhee, K. Y. & Ehrt, S. Growth of Mycobacterium tuberculosis at acidic pH depends on lipid assimilation and is accompanied by reduced GAPDH activity. Proc. Natl. Acad. Sci. USA 118, e2024571118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"8841_CR27","doi-asserted-by":"publisher","first-page":"e0229524","DOI":"10.1128\/spectrum.02295-24","volume":"13","author":"D Luo","year":"2025","unstructured":"Luo, D., Xie, W. & Wang, Z. Curcumin enhances bedaquiline\u2019s efficacy against Mycobacterium abscessus: in vitro and in vivo evidence. Microbiol. Spectr. 13, e0229524 (2025).","journal-title":"Microbiol. Spectr."},{"key":"8841_CR28","doi-asserted-by":"publisher","first-page":"126720","DOI":"10.1016\/j.vaccine.2025.126720","volume":"48","author":"W Xie","year":"2025","unstructured":"Xie, W., Luo, D., Soni, V. & Wang, Z. Functional characterization of MMAR_1296 in Mycobacterium marinum and its potential as a vaccine candidate. Vaccine 48, 126720 (2025).","journal-title":"Vaccine"},{"key":"8841_CR29","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1021\/acsinfecdis.6b00150","volume":"2","author":"JC Evans","year":"2016","unstructured":"Evans, J. C. et al. Validation of CoaBC as a bactericidal target in the coenzyme a pathway of Mycobacterium tuberculosis. ACS Infect. Dis. 2, 958\u2013968 (2016).","journal-title":"ACS Infect. Dis."},{"key":"8841_CR30","doi-asserted-by":"publisher","DOI":"10.15252\/msb.202211099","volume":"19","author":"K Borah Slater","year":"2023","unstructured":"Borah Slater, K. et al. One-shot 13 C15 N-metabolic flux analysis for simultaneous quantification of carbon and nitrogen flux. Mol. Syst. Biol. 19, e11099 (2023).","journal-title":"Mol. Syst. Biol."},{"key":"8841_CR31","doi-asserted-by":"publisher","first-page":"e01715","DOI":"10.1128\/mBio.01715-19","volume":"10","author":"WH DePas","year":"2019","unstructured":"DePas, W. H., Bergkessel, M. & Newman, D. K. Aggregation of nontuberculous mycobacteria is regulated by carbon-nitrogen balance. mBio 10, e01715\u2013e01719 (2019).","journal-title":"mBio"},{"key":"8841_CR32","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1164\/ajrccm\/145.5.1223","volume":"145","author":"L Heifets","year":"1992","unstructured":"Heifets, L. & Lindholm-Levy, P. Pyrazinamide sterilizing activity in vitro against semidormant Mycobacterium tuberculosis bacterial populations. Am. Rev. Respir. Dis. 145, 1223\u20131225 (1992).","journal-title":"Am. Rev. Respir. Dis."},{"key":"8841_CR33","first-page":"491","volume":"4","author":"L Heifets","year":"2000","unstructured":"Heifets, L., Higgins, M. & Simon, B. Pyrazinamide is not active against Mycobacterium tuberculosis residing in cultured human monocyte-derived macrophages. Int. J. Tuberc. Lung Dis. 4, 491\u2013495 (2000).","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"8841_CR34","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0962-8479(96)90045-3","volume":"77","author":"JA Sbarbaro","year":"1996","unstructured":"Sbarbaro, J. A., Iseman, M. D. & Crowle, A. J. Combined effect of pyrazinamide and ofloxacin within the human macrophage. Tube Lung Dis. 77, 491\u2013495 (1996).","journal-title":"Tube Lung Dis."},{"key":"8841_CR35","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0041-3879(85)90040-6","volume":"66","author":"DA Mitchison","year":"1985","unstructured":"Mitchison, D. A. The action of antituberculosis drugs in short-course chemotherapy. Tubercle 66, 219\u2013225 (1985).","journal-title":"Tubercle"},{"key":"8841_CR36","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.advms.2015.09.007","volume":"61","author":"M Njire","year":"2016","unstructured":"Njire, M. et al. Pyrazinamide resistance in Mycobacterium tuberculosis: Review and update. Adv. Med. Sci. 61, 63\u201371 (2016).","journal-title":"Adv. Med. Sci."},{"key":"8841_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/emi.2014.61","volume":"3","author":"W Shi","year":"2014","unstructured":"Shi, W. et al. Aspartate decarboxylase (PanD) as a new target of pyrazinamide in Mycobacterium tuberculosis. Emerg. Microbes Infect. 3, 1\u20138 (2014).","journal-title":"Emerg. Microbes Infect."},{"key":"8841_CR38","doi-asserted-by":"publisher","first-page":"7258","DOI":"10.1128\/AAC.04028-14","volume":"58","author":"NA Dillon","year":"2014","unstructured":"Dillon, N. A., Peterson, N. D., Rosen, B. C. & Baughn, A. D. Pantothenate and pantetheine antagonize the antitubercular activity of pyrazinamide. Antimicrobial Agents Chemother. 58, 7258\u20137263 (2014).","journal-title":"Antimicrobial Agents Chemother."},{"key":"8841_CR39","doi-asserted-by":"publisher","first-page":"102301","DOI":"10.1016\/j.tube.2022.102301","volume":"138","author":"F Nicola","year":"2023","unstructured":"Nicola, F., Cirillo, D. M. & Lor\u00e8, N. I. Preclinical murine models to study lung infection with Mycobacterium abscessus complex. Tuberculosis 138, 102301 (2023).","journal-title":"Tuberculosis"},{"key":"8841_CR40","doi-asserted-by":"publisher","first-page":"102243","DOI":"10.1016\/j.tube.2022.102243","volume":"136","author":"PT Shah","year":"2022","unstructured":"Shah, P. T., Tufail, M., Wu, C. & Xing, L. THP-1 cell line model for tuberculosis: a platform for in vitro macrophage manipulation. Tuberculosis 136, 102243 (2022).","journal-title":"Tuberculosis"},{"key":"8841_CR41","doi-asserted-by":"crossref","unstructured":"Lee, J.-Y. et al. Nucleotide-binding oligomerization domain 2 contributes to limiting growth of Mycobacterium abscessus in the lung of mice by regulating cytokines and nitric oxide production. Front. Immunol. 8, 1477 (2017).","DOI":"10.3389\/fimmu.2017.01477"},{"key":"8841_CR42","doi-asserted-by":"publisher","unstructured":"Kim, T. S. et al. Activity of LCB01-0371, a novel oxazolidinone, against Mycobacterium abscessus. Antimicrobial. Agents Chemotherapy 61, https:\/\/doi.org\/10.1128\/aac.02752-16 (2017).","DOI":"10.1128\/aac.02752-16"},{"key":"8841_CR43","first-page":"852","volume":"59","author":"T Suzuki","year":"2011","unstructured":"Suzuki, T. et al. Detection of Mycobacterium abscessus from blood cultures during treatment of interstitial pneumonia: a case study. Rinsho Byori 59, 852\u2013857 (2011).","journal-title":"Rinsho Byori"},{"key":"8841_CR44","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taaa210","volume":"28","author":"A Pavli","year":"2021","unstructured":"Pavli, A. & Maltezou, H. C. Infectious complications related to medical tourism. J. Travel Med. 28, taaa210 (2021).","journal-title":"J. Travel Med."},{"key":"8841_CR45","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/01652176.2018.1447171","volume":"38","author":"E Hashish","year":"2018","unstructured":"Hashish, E. et al. Mycobacterium marinum infection in fish and man: epidemiology, pathophysiology and management; a review. Vet. Q 38, 35\u201346 (2018).","journal-title":"Vet. Q"},{"key":"8841_CR46","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0769-2609(85)80058-2","volume":"136A","author":"N Mor","year":"1985","unstructured":"Mor, N. & Levy, L. Importance of the footpad lesion in the mouse response to local inoculation of Mycobacterium marinum. Ann. Inst. Pasteur. Microbiol.136A, 191\u2013201 (1985).","journal-title":"Ann. Inst. Pasteur. Microbiol."},{"key":"8841_CR47","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/imr.12960","volume":"301","author":"LB Adams","year":"2021","unstructured":"Adams, L. B. Susceptibility and resistance in leprosy: studies in the mouse model. Immunol. Rev. 301, 157\u2013174 (2021).","journal-title":"Immunol. Rev."},{"key":"8841_CR48","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1128\/iai.11.5.1079-1087.1975","volume":"11","author":"FM Collins","year":"1975","unstructured":"Collins, F. M., Montalbine, V. & Morrison, N. E. Growth and immunogenicity of photochromogenic strains of mycobacteria in the footpads of normal mice. Infect. Immun. 11, 1079\u20131087 (1975).","journal-title":"Infect. Immun."},{"key":"8841_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.829870","volume":"13","author":"Y Ye","year":"2022","unstructured":"Ye, Y. et al. PPAR\u03b3 ameliorates Mycobacterium tuberculosis H37Ra-induced foamy macrophage formation via the ABCG1-dependent cholesterol efflux pathway in THP-1 macrophages. Front. Microbiol. 13, 829870 (2022).","journal-title":"Front. Microbiol."},{"key":"8841_CR50","doi-asserted-by":"publisher","first-page":"e1000204","DOI":"10.1371\/journal.ppat.1000204","volume":"4","author":"P Peyron","year":"2008","unstructured":"Peyron, P. et al. Foamy macrophages from tuberculous patients\u2019 granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathog. 4, e1000204 (2008).","journal-title":"PLoS Pathog."},{"key":"8841_CR51","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.mib.2017.11.020","volume":"41","author":"G Gago","year":"2018","unstructured":"Gago, G., Diacovich, L. & Gramajo, H. Lipid metabolism and its implication in mycobacteria-host interaction. Curr. Opin. Microbiol. 41, 36\u201342 (2018).","journal-title":"Curr. Opin. Microbiol."},{"key":"8841_CR52","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.3389\/fmicb.2016.01086","volume":"7","author":"J Long","year":"2016","unstructured":"Long, J. et al. Plasma membrane profiling reveals upregulation of ABCA1 by infected macrophages leading to restriction of mycobacterial growth. Front. Microbiol. 7, 1086 (2016).","journal-title":"Front. Microbiol."},{"key":"8841_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2021.02.025","volume":"518","author":"W Chen","year":"2021","unstructured":"Chen, W. et al. The ABCA1-efferocytosis axis: a new strategy to protect against atherosclerosis. Clin. Chim. Acta 518, 1\u20138 (2021).","journal-title":"Clin. Chim. Acta"},{"key":"8841_CR54","doi-asserted-by":"publisher","first-page":"6003","DOI":"10.1021\/acs.biochem.8b00871","volume":"57","author":"L Favrot","year":"2018","unstructured":"Favrot, L., Amorim Franco, T. M. & Blanchard, J. S. Biochemical characterization of the Mycobacterium smegmatis threonine deaminase. Biochemistry 57, 6003\u20136012 (2018).","journal-title":"Biochemistry"},{"key":"8841_CR55","doi-asserted-by":"publisher","first-page":"4976","DOI":"10.1073\/pnas.1400390111","volume":"111","author":"H Eoh","year":"2014","unstructured":"Eoh, H. & Rhee, K. Y. Methylcitrate cycle defines the bactericidal essentiality of isocitrate lyase for survival of Mycobacterium tuberculosis on fatty acids. Proc. Natl. Acad. Sci. USA 111, 4976\u20134981 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"8841_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4369","volume":"5","author":"A Koul","year":"2014","unstructured":"Koul, A. et al. Delayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism. Nat. Commun. 5, 3369 (2014).","journal-title":"Nat. Commun."},{"key":"8841_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19959-4","volume":"11","author":"JS Mackenzie","year":"2020","unstructured":"Mackenzie, J. S. et al. Bedaquiline reprograms central metabolism to reveal glycolytic vulnerability in Mycobacterium tuberculosis. Nat. Commun. 11, 6092 (2020).","journal-title":"Nat. Commun."},{"key":"8841_CR58","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1128\/AAC.05363-11","volume":"56","author":"S Reiss","year":"2012","unstructured":"Reiss, S. et al. Global analysis of the Staphylococcus aureus response to mupirocin. Antimicrob. Agents Chemother. 56, 787\u2013804 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"8841_CR59","doi-asserted-by":"publisher","first-page":"105000","DOI":"10.1016\/j.micinf.2022.105000","volume":"24","author":"N Singh","year":"2022","unstructured":"Singh, N., Chauhan, A., Kumar, R. & Singh, S. K. Mycobacterium tuberculosis ketol-acid reductoisomerase down-regulation affects its ability to persist, and its survival in macrophages and in mice. Microbes Infect. 24, 105000 (2022).","journal-title":"Microbes Infect."},{"key":"8841_CR60","doi-asserted-by":"publisher","first-page":"605662","DOI":"10.3389\/fcimb.2020.605662","volume":"10","author":"HS Butman","year":"2020","unstructured":"Butman, H. S., Kotz\u00e9, T. J., Dowd, C. S. & Strauss, E. Vitamin in the crosshairs: targeting pantothenate and coenzyme A biosynthesis for new antituberculosis agents. Front. Cell Infect. Microbiol. 10, 605662 (2020).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"8841_CR61","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1021\/acsinfecdis.2c00133","volume":"8","author":"W-G Saw","year":"2022","unstructured":"Saw, W.-G. et al. Structural and mechanistic insights into Mycobacterium abscessus aspartate decarboxylase PanD and a pyrazinoic acid-derived inhibitor. ACS Infect. Dis. 8, 1324\u20131335 (2022).","journal-title":"ACS Infect. Dis."},{"key":"8841_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms1060","volume":"1","author":"K Pethe","year":"2010","unstructured":"Pethe, K. et al. A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy. Nat. Commun. 1, 1\u20138 (2010).","journal-title":"Nat. Commun."},{"key":"8841_CR63","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nm1252","volume":"11","author":"EJ Mu\u00f1oz-El\u00edas","year":"2005","unstructured":"Mu\u00f1oz-El\u00edas, E. J. & McKinney, J. D. M. tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nat. Med. 11, 638\u2013644 (2005).","journal-title":"Nat. Med."},{"key":"8841_CR64","doi-asserted-by":"publisher","first-page":"431","DOI":"10.4049\/jimmunol.2200306","volume":"210","author":"C Kajiwara","year":"2023","unstructured":"Kajiwara, C. et al. Apoptosis inhibitor of macrophages contributes to the chronicity of Mycobacterium avium Infection by promoting foamy macrophage formation. J. Immunol. 210, 431\u2013441 (2023).","journal-title":"J. Immunol."},{"key":"8841_CR65","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/imr.12952","volume":"301","author":"T Laval","year":"2021","unstructured":"Laval, T., Chaumont, L. & Demangel, C. Not too fat to fight: the emerging role of macrophage fatty acid metabolism in immunity to Mycobacterium tuberculosis. Immunol. Rev. 301, 84\u201397 (2021).","journal-title":"Immunol. Rev."},{"key":"8841_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1067464","volume":"13","author":"A D\u00edaz","year":"2023","unstructured":"D\u00edaz, A. et al. Studies on the contribution of PPAR Gamma to tuberculosis physiopathology. Front. Cell Infect. Microbiol. 13, 1067464 (2023).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"8841_CR67","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1021\/acsinfecdis.3c00731","volume":"10","author":"J Wu","year":"2024","unstructured":"Wu, J., Zhang, Y., Tang, H. & Ye, B.-C. MicroRNA-144-3p inhibits host lipid catabolism and autophagy by targeting PPAR\u03b1 and ABCA1 during Mycobacterium Tuberculosis infection. ACS Infect. Dis. 10, 1654\u20131663 (2024).","journal-title":"ACS Infect. Dis."},{"key":"8841_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/srep27997","volume":"6","author":"R Sharma","year":"2016","unstructured":"Sharma, R., Keshari, D., Singh, K. S., Yadav, S. & Singh, S. K. MRA_1571 is required for isoleucine biosynthesis and improves Mycobacterium tuberculosis H37Ra survival under stress. Sci. Rep. 6, 27997 (2016).","journal-title":"Sci. Rep."},{"key":"8841_CR69","doi-asserted-by":"publisher","first-page":"5882","DOI":"10.1128\/AEM.00882-08","volume":"74","author":"VK Singh","year":"2008","unstructured":"Singh, V. K. et al. Insertional inactivation of branched-chain \u03b1-keto acid dehydrogenase in Staphylococcus aureus leads to decreased branched-chain membrane fatty acid content and increased susceptibility to certain stresses. Appl. Environ. Microbiol. 74, 5882\u20135890 (2008).","journal-title":"Appl. Environ. Microbiol."},{"key":"8841_CR70","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S0092-8674(01)00236-7","volume":"104","author":"MS Glickman","year":"2001","unstructured":"Glickman, M. S. & Jacobs, W. R. Microbial pathogenesis of Mycobacterium tuberculosis: dawn of a discipline. Cell 104, 477\u2013485 (2001).","journal-title":"Cell"},{"key":"8841_CR71","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.chom.2010.12.004","volume":"9","author":"A Venugopal","year":"2011","unstructured":"Venugopal, A. et al. Virulence of Mycobacterium tuberculosis depends on lipoamide dehydrogenase, a member of three multienzyme complexes. Cell Host Microbe 9, 21\u201331 (2011).","journal-title":"Cell Host Microbe"},{"key":"8841_CR72","doi-asserted-by":"publisher","first-page":"47387","DOI":"10.1074\/jbc.M109089200","volume":"276","author":"T Nakama","year":"2001","unstructured":"Nakama, T., Nureki, O. & Yokoyama, S. Structural basis for the recognition of isoleucyl-adenylate and an antibiotic, mupirocin, by isoleucyl-tRNA synthetase. J. Biol. Chem. 276, 47387\u201347393 (2001).","journal-title":"J. Biol. Chem."},{"key":"8841_CR73","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.chembiol.2014.08.020","volume":"21","author":"P Murima","year":"2014","unstructured":"Murima, P., McKinney, J. D. & Pethe, K. Targeting bacterial central metabolism for drug development. Chem. Biol. 21, 1423\u20131432 (2014).","journal-title":"Chem. Biol."},{"key":"8841_CR74","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.chembiol.2014.08.007","volume":"21","author":"B DeLaBarre","year":"2014","unstructured":"DeLaBarre, B., Hurov, J., Cianchetta, G., Murray, S. & Dang, L. Action at a distance: allostery and the development of drugs to target cancer cell metabolism. Chem. Biol. 21, 1143\u20131161 (2014).","journal-title":"Chem. Biol."},{"key":"8841_CR75","doi-asserted-by":"publisher","first-page":"7503","DOI":"10.1073\/pnas.1600630113","volume":"113","author":"M Kasbekar","year":"2016","unstructured":"Kasbekar, M. et al. Selective small molecule inhibitor of the Mycobacterium tuberculosis fumarate hydratase reveals an allosteric regulatory site. Proc. Natl. Acad. Sci. USA 113, 7503\u20137508 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"8841_CR76","doi-asserted-by":"publisher","first-page":"7788","DOI":"10.1021\/acs.jmedchem.9b00582","volume":"62","author":"W Zhong","year":"2019","unstructured":"Zhong, W. et al. Thienopyrimidinone derivatives that inhibit bacterial tRNA (Guanine37-N1)-methyltransferase (TrmD) by restructuring the active site with a tyrosine-flipping mechanism. J. Med. Chem. 62, 7788\u20137805 (2019).","journal-title":"J. Med. Chem."},{"key":"8841_CR77","doi-asserted-by":"publisher","first-page":"19143","DOI":"10.1021\/acs.jmedchem.4c01594","volume":"67","author":"M Andrade Meirelles","year":"2024","unstructured":"Andrade Meirelles, M. et al. Rational exploration of 2,4-diaminopyrimidines as DHFR inhibitors active against Mycobacterium abscessus and Mycobacterium avium, two emerging human pathogens. J. Med. Chem. 67, 19143\u201319164 (2024).","journal-title":"J. Med. Chem."},{"key":"8841_CR78","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s40203-018-0045-5","volume":"6","author":"C Kozhikkadan Davis","year":"2018","unstructured":"Kozhikkadan Davis, C., Nasla, K., Anjana, A. K. & Rajanikant, G. K. Taxifolin as dual inhibitor of Mtb DNA gyrase and isoleucyl-tRNA synthetase: in silico molecular docking, dynamics simulation and in vitro assays.  Silico Pharm. 6, 8 (2018).","journal-title":"Silico Pharm."},{"key":"8841_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-31157-3","volume":"8","author":"R Soto","year":"2018","unstructured":"Soto, R. et al. Identification and characterization of aspartyl-tRNA synthetase inhibitors against Mycobacterium tuberculosis by an integrated whole-cell target-based approach. Sci. Rep. 8, 12664 (2018).","journal-title":"Sci. Rep."},{"key":"8841_CR80","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nrd2201","volume":"6","author":"DJ Payne","year":"2007","unstructured":"Payne, D. J., Gwynn, M. N., Holmes, D. J. & Pompliano, D. L. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat. Rev. Drug Discov. 6, 29\u201340 (2007).","journal-title":"Nat. Rev. Drug Discov."},{"key":"8841_CR81","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1021\/cb300340j","volume":"7","author":"DE Anderson","year":"2012","unstructured":"Anderson, D. E. et al. Comparison of small molecule inhibitors of the bacterial cell division protein FtsZ and identification of a reliable cross-species inhibitor. ACS Chem. Biol. 7, 1918\u20131928 (2012).","journal-title":"ACS Chem. Biol."},{"key":"8841_CR82","doi-asserted-by":"publisher","first-page":"f105","DOI":"10.1136\/bmj.f105","volume":"346","author":"I Chalmers","year":"2013","unstructured":"Chalmers, I., Glasziou, P. & Godlee, F. All trials must be registered and the results published. BMJ 346, f105 (2013).","journal-title":"BMJ"},{"key":"8841_CR83","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S0140-6736(04)17034-7","volume":"364","author":"C De Angelis","year":"2004","unstructured":"De Angelis, C. et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Lancet 364, 911\u2013912 (2004).","journal-title":"Lancet"},{"key":"8841_CR84","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.163","volume":"3","author":"A Hayes","year":"2015","unstructured":"Hayes, A. Key role of publication of clinical data for target validation. Pharm. Res. Perspect. 3, e00163 (2015).","journal-title":"Pharm. Res. Perspect."},{"key":"8841_CR85","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201949775","volume":"21","author":"S Nimpf","year":"2020","unstructured":"Nimpf, S. & Keays, D. A. Why (and how) we should publish negative data. EMBO Rep. 21, e49775 (2020).","journal-title":"EMBO Rep."},{"key":"8841_CR86","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/978-1-0716-1460-0_27","volume":"2314","author":"B Gold","year":"2021","unstructured":"Gold, B., Warrier, T. & Nathan, C. A multistress model for high throughput screening against nonreplicating Mycobacterium tuberculosis. Methods Mol. Biol. 2314, 611\u2013635 (2021).","journal-title":"Methods Mol. Biol."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08841-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08841-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08841-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T09:05:28Z","timestamp":1759136728000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08841-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8841"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-08841-y","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"7 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1379"}}